These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24007371)

  • 1. Incidence, clinical spectrum, diagnostic features, treatment and predictors of paradoxical reactions during antibiotic treatment of Mycobacterium ulcerans infections.
    O'Brien DP; Robson M; Friedman ND; Walton A; McDonald A; Callan P; Hughes A; Rahdon R; Athan E
    BMC Infect Dis; 2013 Sep; 13():416. PubMed ID: 24007371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic complications during the treatment of Mycobacterium ulcerans disease in Australian patients.
    O'Brien DP; Friedman D; Hughes A; Walton A; Athan E
    Intern Med J; 2017 Sep; 47(9):1011-1019. PubMed ID: 28585259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wound healing: Natural history and risk factors for delay in Australian patients treated with antibiotics for Mycobacterium ulcerans disease.
    O'Brien DP; Friedman ND; McDonald A; Callan P; Hughes A; Walton A; Athan E
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006357. PubMed ID: 29554101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study.
    O'Brien DP; McDonald A; Callan P; Robson M; Friedman ND; Hughes A; Holten I; Walton A; Athan E
    PLoS Negl Trop Dis; 2012 Jan; 6(1):e1473. PubMed ID: 22272368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium ulcerans in the Elderly: More Severe Disease and Suboptimal Outcomes.
    O'Brien DP; Friedman ND; Cowan R; Pollard J; McDonald A; Callan P; Hughes A; Athan E
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004253. PubMed ID: 26630648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and risk factors of oedematous Mycobacterium ulcerans lesions in an Australian population: beware cellulitis in an endemic area.
    O'Brien DP; Friedman ND; McDonald A; Callan P; Hughes A; Athan E
    PLoS Negl Trop Dis; 2014; 8(1):e2612. PubMed ID: 24392172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paediatric Buruli ulcer in Australia.
    Walker G; Friedman DN; O'Brien MP; Cooper C; McDonald A; Callan P; O'Brien DP
    J Paediatr Child Health; 2020 Apr; 56(4):636-641. PubMed ID: 31821679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium ulcerans in the Daintree 2009-2015 and the mini-epidemic of 2011.
    Steffen CM; Freeborn H
    ANZ J Surg; 2018 Apr; 88(4):E289-E293. PubMed ID: 27804194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Paradoxical reactions and responses during antibiotic treatment for Mycobacterium ulcerans infection (Buruli ulcer). Four cases from French Guiana].
    Sambourg E; Dufour J; Edouard S; Morris A; Mosnier E; Reynaud Y; Sainte-Marie D; Nacher M; Guégan JF; Couppié P
    Ann Dermatol Venereol; 2014; 141(6-7):413-8. PubMed ID: 24951139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium ulcerans treatment--can antibiotic duration be reduced in selected patients?
    Cowan R; Athan E; Friedman ND; Hughes AJ; McDonald A; Callan P; Fyfe J; O'Brien DP
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003503. PubMed ID: 25658304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology, clinical features and diagnosis of Mycobacterium ulcerans in an Australian population.
    Boyd SC; Athan E; Friedman ND; Hughes A; Walton A; Callan P; McDonald A; O'Brien DP
    Med J Aust; 2012 Mar; 196(5):341-4. PubMed ID: 22432674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and management of a severe paradoxical reaction associated with combined treatment of Buruli ulcer and HIV co-infection.
    Wanda F; Nkemenang P; Ehounou G; Tchaton M; Comte E; Toutous Trellu L; Masouyé I; Christinet V; O'Brien DP
    BMC Infect Dis; 2014 Jul; 14():423. PubMed ID: 25073531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort.
    Friedman ND; Athan E; Walton AL; O'Brien DP
    Antimicrob Agents Chemother; 2016 May; 60(5):2692-5. PubMed ID: 26883709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease).
    Kibadi K; Boelaert M; Fraga AG; Kayinua M; Longatto-Filho A; Minuku JB; Mputu-Yamba JB; Muyembe-Tamfum JJ; Pedrosa J; Roux JJ; Meyers WM; Portaels F
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e736. PubMed ID: 20625556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical reactions in Buruli ulcer after initiation of antibiotic therapy: Relationship to bacterial load.
    Frimpong M; Agbavor B; Duah MS; Loglo A; Sarpong FN; Boakye-Appiah J; Abass KM; Dongyele M; Amofa G; Tuah W; Frempong M; Amoako YA; Wansbrough-Jones M; Phillips RO
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007689. PubMed ID: 31449522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six vs Eight Weeks of Antibiotics for Small Mycobacterium ulcerans Lesions in Australian Patients.
    O'Brien DP; Friedman ND; Cowan R; Walton A; Athan E
    Clin Infect Dis; 2020 Apr; 70(9):1993-1997. PubMed ID: 31231766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for recurrent Mycobacterium ulcerans disease after exclusive surgical treatment in an Australian cohort.
    O'Brien DP; Walton A; Hughes AJ; Friedman ND; McDonald A; Callan P; Rhadon R; Holten I; Athan E
    Med J Aust; 2013 May; 198(8):436-9. PubMed ID: 23641995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Paradoxical" immune-mediated reactions to Mycobacterium ulcerans during antibiotic treatment: a result of treatment success, not failure.
    O'Brien DP; Robson ME; Callan PP; McDonald AH
    Med J Aust; 2009 Nov; 191(10):564-6. PubMed ID: 19912091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial.
    Nienhuis WA; Stienstra Y; Thompson WA; Awuah PC; Abass KM; Tuah W; Awua-Boateng NY; Ampadu EO; Siegmund V; Schouten JP; Adjei O; Bretzel G; van der Werf TS
    Lancet; 2010 Feb; 375(9715):664-72. PubMed ID: 20137805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium ulcerans disease: experience with primary oral medical therapy in an Australian cohort.
    Friedman ND; Athan E; Hughes AJ; Khajehnoori M; McDonald A; Callan P; Rahdon R; O'Brien DP
    PLoS Negl Trop Dis; 2013; 7(7):e2315. PubMed ID: 23875050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.